智通财经APP获悉,赛诺菲(SNY.US)第一季度利润超预期,其重磅皮肤科和哮喘药物Dupixent的强劲需求功不可没。财报显示,赛诺菲一季度营收为 98.9 亿欧元,同比下降 5.4%,超出预期 1.2 亿欧元;经项目调整后的每股收益为1.79欧元(合2.03美元),高于分析师预估的1.67欧元。这家法国制药商重申了全年业绩指引,称已考虑美国关税和全球经济不确定性的潜在影响。2025年,赛诺菲...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.